Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs

被引:104
作者
Simonsen, L [1 ]
Holst, JJ [1 ]
Deacon, CF [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark
关键词
dipeptidyl peptidase IV; exendin-4; glomerular filtration rate; glucagon-like peptide-1; incretin; kidney; metabolism; neutral endopeptidase 24.11;
D O I
10.1007/s00125-005-0128-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis: The insulinotropic hormone, glucagon-like peptide-1 (GLP-1), is rapidly degraded in vivo as a result of the combination of extensive enzymatic degradation and renal extraction. The GLP-1 receptor agonist, exendin-4, has a longer duration of action, and has recently been approved as a new agent for the treatment of type 2 diabetes mellitus. Exendin-4 is less prone to enzymatic degradation, but it is still unclear what other factors contribute to the increased metabolic stability. Materials and methods: The overall metabolism of GLP-1 and exendin-4 was directly compared in anaesthetised pigs (n=9). Results: Metabolism of GLP-1 (C-terminal RIA; t(1/2) 2.0 +/- 0.2 min, metabolic clearance rate [MCR] 23.2 +/- 2.8 ml min(-1) kg(-1); N-terminal RIA; t(1/2) 1.5 +/- 0.2 min, MCR 88.1 +/- 10.6 ml min(-1) kg(-1)) was significantly faster than the metabolism of exendin-4 (t(1/2) 22.0 +/- 2.1 min, p < 0.0001; MCR 1.7 +/- 0.3 ml min(-1) kg(-1), p < 0.01). Differences in arteriovenous concentrations revealed organ extraction of GLP-1 by the kidneys (C-terminal 56.6 +/- 2.6%; N-terminal 48.3 +/- 5.9%), liver (N-terminal 41.4 +/- 3.8%), and peripheral tissues (C-terminal 42.3 +/- 6.0%; N-terminal 33.0 +/- 7.8%), whereas organ extraction of exendin-4 was limited to the kidneys (21.3 +/- 4.9%). While the renal extraction of exendin-4 (6.9 +/- 2.5 pmol/min) did not differ significantly from the amount undergoing glomerular filtration (8.4 +/- 2.0 pmol/min), the renal extraction of C-terminal GLP-1 (9.0 +/- 1.1 pmol/min), exceeded the amount which could be accounted for by glomerular filtration (4.2 +/- 0.5 pmol/min, p < 0.0005). Conclusions/interpretation: In addition to an increased resistance to enzymatic degradation, the increased stability of exendin-4 is the result of reduced differential organ extraction compared to GLP-1. The data suggest that in the anaesthetised pig, extraction occurs only in the kidney and can be fully accounted for by glomerular filtration.
引用
收藏
页码:706 / 712
页数:7
相关论文
共 33 条
[1]   PROTEINS OF KIDNEY MICROVILLUS MEMBRANE - IDENTIFICATION OF SUBUNITS AFTER SODIUM DODECYL SULFATE-POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].
BOOTH, AG ;
KENNY, AJ .
BIOCHEMICAL JOURNAL, 1976, 159 (02) :395-&
[2]  
CARONE FA, 1982, J LAB CLIN MED, V100, P1
[3]   Inhibitors of dipeptidyl peptidase IV:: a novel approach for the prevention and treatment of Type 2 diabetes? [J].
Deacon, CF ;
Ahrén, B ;
Holst, JJ .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) :1091-1102
[4]   Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs [J].
Deacon, CF ;
Danielson, P ;
Klarskov, L ;
Olesen, M ;
Holst, JJ .
DIABETES, 2001, 50 (07) :1588-1597
[5]   Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig [J].
Deacon, CF ;
Pridal, L ;
Klarskov, L ;
Olesen, M ;
Holst, JJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 271 (03) :E458-E464
[6]   Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers [J].
Edwards, CMB ;
Stanley, SA ;
Davis, R ;
Brynes, AE ;
Frost, GS ;
Seal, LJ ;
Ghatei, MA ;
Bloom, SR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (01) :E155-E161
[7]   GLUCAGON METABOLISM IN RAT - CONTRIBUTION OF KIDNEY TO METABOLIC-CLEARANCE RATE OF HORMONE [J].
EMMANOUEL, DS ;
JASPAN, JB ;
RUBENSTEIN, AH ;
HUEN, AHJ ;
FINK, E ;
KATZ, AI .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01) :6-13
[8]  
ENG J, 1992, J BIOL CHEM, V267, P7402
[9]   GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE - CHARACTERIZATION OF THE DOMAIN RESPONSIBLE FOR BINDING TO ITS RECEPTOR ON RAT INSULINOMA RINM5F CELLS [J].
GALLWITZ, B ;
SCHMIDT, WE ;
CONLON, JM ;
CREUTZFELDT, W .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1990, 5 (01) :33-39
[10]   In vivo and in vitro degradation of glucagon-like peptide-2 in humans [J].
Hartmann, B ;
Harr, MB ;
Jeppesen, PB ;
Wojdemann, M ;
Deacon, CF ;
Mortensen, PB ;
Holst, JJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2884-2888